Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray W Huff

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Journal of Lipid Research|February 4, 2003
Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoBDawn E Telford, Jane Y Edwards, Sara M Lipson, et al.
Diabetes|July 14, 2009
Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistanceErin E Mulvihill, Emma M Allister, Brian G Sutherland, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 15, 2014
G-protein estrogen receptor as a regulator of low-density lipoprotein cholesterol metabolism: cellular and population genetic studiesYasin Hussain, Qingming Ding, Philip W Connelly, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 8, 2005
A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol contentDawn E Telford, Sara M Lipson, P Hugh R Barrett, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 4, 2017
Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in <i>Ldlr</i> Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempedoic AcidJoshua P Samsoondar, Amy C Burke, Brian G Sutherland, et al.
Human Molecular Genetics|July 4, 2008
Polygenic determinants of severe hypertriglyceridemiaJian Wang, Matthew R Ban, Guang Yong Zou, et al.
Journal of Lipid Research|December 28, 2012
Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr⁻/⁻ miceJulia M Assini, Erin E Mulvihill, Brian G Sutherland, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2018
Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (<i>LDLR</i><sup>+/-</sup> and <i>LDLR</i><sup>-/-</sup>) Yucatan Miniature PigsAmy C Burke, Dawn E Telford, Brian G Sutherland, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 2021
Nobiletin Prevents High-Fat Diet-Induced Dysregulation of Intestinal Lipid Metabolism and Attenuates Postprandial LipemiaNadya M Morrow, Natasha A Trzaskalski, Antonio A Hanson, et al.
Journal of Lipid Research|October 9, 2009
APOC1 T45S polymorphism is associated with reduced obesity indices and lower plasma concentrations of leptin and apolipoprotein C-I in aboriginal CanadiansPiya Lahiry, Henian Cao, Matthew R Ban, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Journal of Lipid Research|February 4, 2003
Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoBDawn E Telford, Jane Y Edwards, Sara M Lipson, et al.
Diabetes|July 14, 2009
Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistanceErin E Mulvihill, Emma M Allister, Brian G Sutherland, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 15, 2014
G-protein estrogen receptor as a regulator of low-density lipoprotein cholesterol metabolism: cellular and population genetic studiesYasin Hussain, Qingming Ding, Philip W Connelly, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 8, 2005
A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol contentDawn E Telford, Sara M Lipson, P Hugh R Barrett, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 4, 2017
Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in <i>Ldlr</i> Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempedoic AcidJoshua P Samsoondar, Amy C Burke, Brian G Sutherland, et al.
Human Molecular Genetics|July 4, 2008
Polygenic determinants of severe hypertriglyceridemiaJian Wang, Matthew R Ban, Guang Yong Zou, et al.
Journal of Lipid Research|December 28, 2012
Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr⁻/⁻ miceJulia M Assini, Erin E Mulvihill, Brian G Sutherland, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2018
Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (<i>LDLR</i><sup>+/-</sup> and <i>LDLR</i><sup>-/-</sup>) Yucatan Miniature PigsAmy C Burke, Dawn E Telford, Brian G Sutherland, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 2021
Nobiletin Prevents High-Fat Diet-Induced Dysregulation of Intestinal Lipid Metabolism and Attenuates Postprandial LipemiaNadya M Morrow, Natasha A Trzaskalski, Antonio A Hanson, et al.
Journal of Lipid Research|October 9, 2009
APOC1 T45S polymorphism is associated with reduced obesity indices and lower plasma concentrations of leptin and apolipoprotein C-I in aboriginal CanadiansPiya Lahiry, Henian Cao, Matthew R Ban, et al.
Pageof 8